- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Real-World Insights and PROMPT-LIPID
Panelists discuss how real-world programs like PROMPT-LIPID expose undertreatment patterns and guide care improvement.
EP: 1.Understanding the Current State of LDL-C Goal Attainment and Barriers to Adequate Control in Hyperlipidemia
EP: 2.Challenges with Undertreatment in Hyperlipidemia and Opportunities to Address this Gap
EP: 3.Pharmacy-Driven Challenges
EP: 4.Real-World Insights and PROMPT-LIPID
EP: 5.Social Determinants of Health
EP: 6.The 2013 Guideline Shift
EP: 7.Unintended Consequences of Metric Changes
EP: 8.Reinstating LDL-C Targets
EP: 9.International LDL Thresholds
EP: 10.Nonstatin Therapy Decisions
EP: 11.PCSK9 Inhibitor Underuse
EP: 12.Payer and Prior Authorization Barriers
EP: 13.Adherence and Persistence
EP: 14.Cumulative LDL-C Exposure
EP: 15.Economic Burden and Systemwide Strategies
Panelists discuss how real-world programs such as PROMPT-LIPID reveal significant undertreatment patterns and missed opportunities in low-density lipoprotein cholesterol (LDL-C) care. Data from such initiatives show that even high-risk patients often fail to reach evidence-based targets.
These findings highlight systemic inefficiencies in care coordination and therapy escalation. Panelists explain that identifying at-risk populations through registry and claims data can guide targeted interventions.
They conclude that learning from real-world models can help close clinical gaps, drive adherence, and improve alignment between guideline recommendations and everyday practice.
